1. Home
  2. OBT vs ALT Comparison

OBT vs ALT Comparison

Compare OBT & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orange County Bancorp Inc.

OBT

Orange County Bancorp Inc.

HOLD

Current Price

$33.45

Market Cap

457.7M

Sector

Finance

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.90

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBT
ALT
Founded
1892
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
457.7M
421.5M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
OBT
ALT
Price
$33.45
$2.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$36.00
$17.67
AVG Volume (30 Days)
31.0K
4.9M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
2.12%
N/A
EPS Growth
34.82
25.37
EPS
0.85
N/A
Revenue
N/A
$41,000.00
Revenue This Year
$14.27
N/A
Revenue Next Year
$7.99
N/A
P/E Ratio
$39.65
N/A
Revenue Growth
N/A
105.00
52 Week Low
$22.84
$2.56
52 Week High
$37.99
$7.73

Technical Indicators

Market Signals
Indicator
OBT
ALT
Relative Strength Index (RSI) 50.71 44.35
Support Level $33.25 $2.87
Resistance Level $36.64 $4.19
Average True Range (ATR) 1.07 0.15
MACD -0.10 0.00
Stochastic Oscillator 32.71 32.41

Price Performance

Historical Comparison
OBT
ALT

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: